We are live on ! Find out more
VTRS icon

Viatris

1,022 hedge funds and large institutions have $16.6B invested in Viatris in 2026 Q2 according to their latest regulatory filings, with 112 funds opening new positions, 362 increasing their positions, 324 reducing their positions, and 96 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% more call options, than puts

Call options by funds: $141M | Put options by funds: $80.7M

24% more capital invested

Capital invested by funds: $13.4B → $16.6B (+$3.2B)

17% more first-time investments, than exits

New positions opened: 112 | Existing positions closed: 96

12% more repeat investments, than reductions

Existing positions increased: 362 | Existing positions reduced: 324

3.62% more ownership

Funds ownership: 86.04%89.66% (+3.6%)

0% less funds holding

Funds holding: 1,0261,022 (-4)

11% less funds holding in top 10

Funds holding in top 10: 1816 (-2)

Holders
1,022
Holders Change
-4
Holders Change %
-0.39%
% of All Funds
12.34%
Holding in Top 10
16
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-11.11%
% of All Funds
0.19%
New
112
Increased
362
Reduced
324
Closed
96
Calls
$141M
Puts
$80.7M
Net Calls
+$59.9M
Net Calls Change
-$63.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$1.53B +$1.24B +80,073,588 +483%
BlackRock
2
BlackRock
New York
$1.37B +$25.7M +1,659,664 +2%
Vanguard Capital Management
3
Vanguard Capital Management
Pennsylvania
$1.21B +$20.6M +1,330,308 +2%
DSA
4
Davis Selected Advisers
Arizona
$1.19B -$46.2M -2,978,937 -4%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$1.08B +$36.4M +2,350,332 +4%
Vanguard Portfolio Management
6
Vanguard Portfolio Management
Pennsylvania
$862M +$5.75M +370,843 +0.7%
State Street
7
State Street
Massachusetts
$843M +$13M +835,762 +2%
RCMNY
8
Rubric Capital Management (New York)
New York
$543M +$10.4M +668,743 +2%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$520M +$14.9M +961,799 +3%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$476M -$129M -8,340,599 -22%
Invesco
11
Invesco
Georgia
$330M -$18.6M -1,197,382 -5%
DM
12
Deerfield Management
New York
$321M
Ameriprise
13
Ameriprise
Minnesota
$299M -$18.6M -1,199,219 -6%
Morgan Stanley
14
Morgan Stanley
New York
$240M -$14.9M -961,040 -6%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$227M +$2.47M +159,136 +1%
Charles Schwab
16
Charles Schwab
California
$215M -$1.66M -106,964 -0.8%
Goldman Sachs
17
Goldman Sachs
New York
$215M -$2.37M -152,750 -1%
Northern Trust
18
Northern Trust
Illinois
$159M -$6.4M -412,673 -4%
GCM
19
Glenview Capital Management
New York
$157M +$12.2M +790,165 +9%
LSV Asset Management
20
LSV Asset Management
Illinois
$136M +$10.3M +664,739 +8%
Arrowstreet Capital
21
Arrowstreet Capital
Massachusetts
$133M -$2.7M -173,978 -2%
CCM
22
Callodine Capital Management
Massachusetts
$127M -$1.83M -118,000 -1%
Deutsche Bank
23
Deutsche Bank
Germany
$125M +$21.4M +1,378,831 +21%
JP Morgan Chase
24
JP Morgan Chase
New York
$120M +$24.7M +1,590,702 +28%
Bank of America
25
Bank of America
North Carolina
$117M +$1.51M +97,153 +1%

VTRS Hedge Fund Activity: Q2 2026 in Review

1,022 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Viatris (VTRS) for Q2 2026, worth a combined $16.6B — up 24% from $13.4B a quarter earlier.

Buyers outnumbered sellers: 112 funds opened new VTRS positions and 96 closed out — a net gain of 16 holders — while 362 added to existing stakes and 324 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $1.24B. The largest seller was Marshall Wace, cutting an estimated $132M.

  • 1,022 institutional investors held Viatris (VTRS) as of Q2 2026, down from 1,026 in Q1 2026.
  • Funds reported $16.6B of Viatris stock for Q2 2026, up 24% quarter-over-quarter.
  • 112 funds opened new Viatris positions in Q2 2026 and 96 closed out, a net change of +16 holders.
  • The largest Viatris buyer in Q2 2026 was Fidelity Investments, an estimated $1.24B added.
  • The largest Viatris seller in Q2 2026 was Marshall Wace, an estimated $132M sold.

Based on aggregated 13F filings for Q2 2026.